Marine Drugs (Apr 2014)

New Benzoxazine Secondary Metabolites from an Arctic Actinomycete

  • Kyuho Moon,
  • Chan-Hong Ahn,
  • Yoonho Shin,
  • Tae Hyung Won,
  • Keebeom Ko,
  • Sang Kook Lee,
  • Ki-Bong Oh,
  • Jongheon Shin,
  • Seung-Il Nam,
  • Dong-Chan Oh

DOI
https://doi.org/10.3390/md12052526
Journal volume & issue
Vol. 12, no. 5
pp. 2526 – 2538

Abstract

Read online

Two new secondary metabolites, arcticoside (1) and C-1027 chromophore-V (2), were isolated along with C-1027 chromophore-III and fijiolides A and B (3–5) from a culture of an Arctic marine actinomycete Streptomyces strain. The chemical structures of 1 and 2 were elucidated through NMR, mass, UV, and IR spectroscopy. The hexose moieties in 1 were determined to be d-glucose from a combination of acid hydrolysis, derivatization, and gas chromatographic analyses. Arcticoside (1) and C-1027 chromophore-V (2), which have a benzoxazine ring, inhibited Candida albicans isocitrate lyase. Chromophore-V (2) exhibited significant cytotoxicity against breast carcinoma MDA-MB231 cells and colorectal carcinoma cells (line HCT-116), with IC50 values of 0.9 and 2.7 μM, respectively.

Keywords